ClinicalTrials.Veeva

Menu

Predictive and Diagnostic Value of BIND Score in Assessment of Severe Neonatal Jaundice Cases in Neonatal Intensive Care Unit

A

Assiut University

Status

Not yet enrolling

Conditions

Neonatal Hyperbilirubinemia

Treatments

Device: Phototherapy

Study type

Observational

Funder types

Other

Identifiers

NCT07150494
Neonatal jaundice cases in nic

Details and patient eligibility

About

Early detection and prevention of neonatal encephalopathy using BIND score.

Enrollment

80 estimated patients

Sex

All

Ages

1 to 28 days old

Volunteers

No Healthy Volunteers

Inclusion criteria

Newborn < 28 days old Neonates with severe hyperbilirubinemia need extensive phototherapy impending exchange transfusion

Exclusion criteria

Age > 28 days old Neonates with any abnormal neurological signs suggesting neurological disease (hypoxic ischemic encephalopathy, muscle disease, …etc.).

Trial contacts and locations

0

Loading...

Central trial contact

Nouralhoda Ahmed Metwally

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems